7th Edition of Cardiology World Conference
October 08-10, 2026 | Virtual Event
Nanotechnology and Cardiovascular Medicine
Incorporating nanotechnology into the field of cardiovascular medicine is paving the way for new treatments that were once unimaginable. Nanotechnology and cardiovascular medicine are being combined to develop more precise drug delivery systems, allowing medication to be delivered directly to the heart, reducing systemic side effects and improving therapeutic outcomes. This breakthrough is also enhancing diagnostic tools, enabling earlier detection of cardiovascular diseases. The potential for nanomaterials to repair or regenerate damaged tissues and blood vessels provides a hopeful outlook for patients suffering from severe cardiovascular diseases. As this field continues to evolve, the integration of nanotechnology promises to redefine the future of heart disease management.
Yochai Birnbaum
Baylor College of Medicine, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Sekib Sokolovic
ASA Hospital, Bosnia and Herzegowina
Sergey Suchkov
N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Syed Raza
Awali Hospital, Bahrain
Sekib Sokolovic
ASA Hospital, Bosnia and Herzegowina
Thomas J Webster
Brown University, United StatesSubmit your abstract Today
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States